Evidence map›Paper›PMID 40636797›Full record

ArticleiLIVER2022

MAFLD was more easily diagnosed than NAFLD in liver transplant recipients with abnormal liver function.

Dali Zhang, Hongbo Wang, Xi He, Danni Feng, Yanling Sun, Zhenwen Liu, Yinjie Gao, Hongling Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iLIVER, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dali ZhangSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Hongbo WangSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Xi HeSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Danni FengSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Yanling SunSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Zhenwen LiuSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Yinjie GaoSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.
Hongling LiuSenior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, No. 100, Xisi Ring Middle Road, Beijing, 100039, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Nonalcoholic fatty liver disease (NAFLD) is hepatic steatosis that is require the exclusion of certain etiologies, including drug usage or alcoholic consumption. Conversely, metabolic dysfunction-associated fatty liver disease (MAFLD) needs not to. In this study, we aimed to examine whether MAFLD is more easily diagnosed than NAFLD in liver transplant (LT) recipients with abnormal liver function. Methods: In this cross-sectional study, LT recipients with abnormal liver function were investigated for the prevalence of MAFLD and NAFLD. Results: We recruited 57 LT recipients with abnormal liver function at a referral hospital. Among these patients, the prevalence of MAFLD and NAFLD was 37.8% and 11.1%, respectively. 17 patients showed hepatic steatosis, with an average NAFLD activity score of 3.5 and a fibrosis score of 1.0. Compared with non-MAFLD patients, MAFLD patients had a significant difference in fasting blood glucose levels ( Conclusions: MAFLD was more easily diagnosed in LT recipients with abnormal liver function and higher in prevalence than NAFLD. A larger sample size research is required to validate these conclusions.

Indexed as

Fasting blood glucoseMetabolic dysfunction-associated fatty liver diseaseNonalcoholic fatty liver diseasePrevalenceRecipient

Identifiers

PMID40636797
PMCPMC12212721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.